2013 Q2 Form 10-Q Financial Statement

#000119312513323276 Filed on August 07, 2013

View on sec.gov

Income Statement

Concept 2013 Q2 2012 Q2
Revenue $78.95M $78.93M
YoY Change 0.03% 7.39%
Cost Of Revenue $29.25M $29.83M
YoY Change -1.93% 6.53%
Gross Profit $49.70M $49.10M
YoY Change 1.22% 8.16%
Gross Profit Margin 62.95% 62.21%
Selling, General & Admin $39.05M $39.07M
YoY Change -0.06% 13.9%
% of Gross Profit 78.56% 79.56%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.302M $2.255M
YoY Change 2.08% 52.36%
% of Gross Profit 4.63% 4.59%
Operating Expenses $39.05M $39.07M
YoY Change -0.06% 9.13%
Operating Profit $9.788M $11.15M
YoY Change -12.23% 16.17%
Interest Expense $100.0K $100.0K
YoY Change 0.0% 0.0%
% of Operating Profit 1.02% 0.9%
Other Income/Expense, Net $255.0K $130.0K
YoY Change 96.15%
Pretax Income $10.14M $11.68M
YoY Change -13.14% 20.36%
Income Tax $3.956M $3.906M
% Of Pretax Income 39.01% 33.46%
Net Earnings $6.185M $7.584M
YoY Change -18.45% 37.89%
Net Earnings / Revenue 7.83% 9.61%
Basic Earnings Per Share $0.29 $0.34
Diluted Earnings Per Share $0.28 $0.33
COMMON SHARES
Basic Shares Outstanding 21.26M shares 22.58M shares
Diluted Shares Outstanding 21.75M shares 23.02M shares

Balance Sheet

Concept 2013 Q2 2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $178.6M $236.4M
YoY Change -24.45% 8.29%
Cash & Equivalents $55.08M $87.66M
Short-Term Investments $123.6M $148.8M
Other Short-Term Assets $25.50M $34.30M
YoY Change -25.66% -1.44%
Inventory
Prepaid Expenses
Receivables $39.79M $47.50M
Other Receivables $0.00 $0.00
Total Short-Term Assets $243.9M $318.3M
YoY Change -23.39% 5.82%
LONG-TERM ASSETS
Property, Plant & Equipment $42.48M $48.80M
YoY Change -12.95% 13.23%
Goodwill $78.48M
YoY Change
Intangibles
YoY Change
Long-Term Investments $8.900M $9.700M
YoY Change -8.25% -42.94%
Other Assets $11.24M $11.70M
YoY Change -3.9% 27.17%
Total Long-Term Assets $147.9M $150.6M
YoY Change -1.8% -1.83%
TOTAL ASSETS
Total Short-Term Assets $243.9M $318.3M
Total Long-Term Assets $147.9M $150.6M
Total Assets $391.8M $468.9M
YoY Change -16.45% 3.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.122M $1.000M
YoY Change 12.2% -62.96%
Accrued Expenses $26.87M $28.80M
YoY Change -6.7% -7.99%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $164.8M $164.3M
YoY Change 0.3% -0.06%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $9.200M
YoY Change
Total Long-Term Liabilities $9.233M $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $164.8M $164.3M
Total Long-Term Liabilities $9.233M $0.00
Total Liabilities $174.0M $181.8M
YoY Change -4.28% 3.35%
SHAREHOLDERS EQUITY
Retained Earnings $119.2M
YoY Change
Common Stock $100.1M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $424.0K
YoY Change
Treasury Stock Shares 11.00K shares
Shareholders Equity $217.7M $287.2M
YoY Change
Total Liabilities & Shareholders Equity $391.8M $468.9M
YoY Change -16.45% 3.24%

Cashflow Statement

Concept 2013 Q2 2012 Q2
OPERATING ACTIVITIES
Net Income $6.185M $7.584M
YoY Change -18.45% 37.89%
Depreciation, Depletion And Amortization $2.302M $2.255M
YoY Change 2.08% 52.36%
Cash From Operating Activities $1.780M $4.510M
YoY Change -60.53% -24.58%
INVESTING ACTIVITIES
Capital Expenditures -$330.0K -$830.0K
YoY Change -60.24% -94.61%
Acquisitions
YoY Change
Other Investing Activities -$3.940M -$6.570M
YoY Change -40.03% 17.11%
Cash From Investing Activities -$4.270M -$7.390M
YoY Change -42.22% -64.81%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -86.46M -8.330M
YoY Change 937.94% 5106.25%
NET CHANGE
Cash From Operating Activities 1.780M 4.510M
Cash From Investing Activities -4.270M -7.390M
Cash From Financing Activities -86.46M -8.330M
Net Change In Cash -88.95M -11.21M
YoY Change 693.49% -26.15%
FREE CASH FLOW
Cash From Operating Activities $1.780M $4.510M
Capital Expenditures -$330.0K -$830.0K
Free Cash Flow $2.110M $5.340M
YoY Change -60.49% -75.01%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20203000 shares
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
87663000
CY2013Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20241000 shares
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20252000 shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
389000 shares
CY2013Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
31.21
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1906000 shares
CY2013Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
28.61
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000 shares
CY2013Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
11000 shares
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
967000 shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
34.14
CY2013Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2013Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
26869000
CY2013Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1122000
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
164794000
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1167000
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
217723000
CY2013Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
99914000
CY2013Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
491000 shares
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.26
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
343000
us-gaap Severance Costs1
SeveranceCosts1
1900000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-241000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
8488000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-24000
CY2012Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
9158000 shares
CY2013Q2 forr Available For Sale Securities Debt Maturities Thereafter Fair Value
AvailableForSaleSecuritiesDebtMaturitiesThereafterFairValue
24822000
CY2013Q2 forr Available For Sale Securities Debt Maturities Year Two Fair Value
AvailableForSaleSecuritiesDebtMaturitiesYearTwoFairValue
42365000
CY2013Q2 forr Cumulative Repurchase Of Common Stock
CumulativeRepurchaseOfCommonStock
11700000 shares
CY2013Q2 forr Available For Sale Securities Debt Maturities Year Three Fair Value
AvailableForSaleSecuritiesDebtMaturitiesYearThreeFairValue
38729000
CY2013Q2 forr Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
2493000
CY2013Q2 forr Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
185000
CY2013Q2 forr Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Aggregate Losses Accumulated In Investments
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsAggregateLossesAccumulatedInInvestments
413000
CY2013Q2 forr Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Aggregate Losses Accumulated In Investments
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerAggregateLossesAccumulatedInInvestments
2080000
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
29.03
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1936000 shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000 shares
CY2013Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
119197000
CY2013Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
136803000
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
203000
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
391750000
CY2013Q2 us-gaap Liabilities
Liabilities
174027000
CY2013Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
9233000
CY2013Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
26554000
CY2013Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
123550000
CY2013Q2 us-gaap Assets Current
AssetsCurrent
243861000
CY2013Q2 us-gaap Goodwill
Goodwill
78480000
CY2013Q2 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
8920000
CY2013Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
134778000
CY2013Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
11244000
CY2013Q2 us-gaap Assets
Assets
391750000
CY2013Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
8920000
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
55083000
CY2013Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
39785000
CY2013Q2 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1000000
CY2013Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
0
CY2013Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
62041000
CY2013Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6767000
CY2013Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
7870000
CY2013Q2 us-gaap Available For Sale Securities
AvailableForSaleSecurities
132470000
CY2013Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
16593000
CY2013Q2 us-gaap Deferred Costs Current
DeferredCostsCurrent
8850000
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
10553000
CY2013Q2 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
139583000
CY2013Q2 us-gaap Treasury Stock Value
TreasuryStockValue
424000
CY2013Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
42478000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
81047000
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22293000 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31451000 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
301000 shares
CY2013Q2 forr Stock Repurchase Program Number Of Shares Purchased Value
StockRepurchaseProgramNumberOfSharesPurchasedValue
74000000
CY2013Q2 forr Stock Repurchase Program Tender Offer Repurchase Maximum Amount
StockRepurchaseProgramTenderOfferRepurchaseMaximumAmount
130000000
CY2013Q2 forr Stock Repurchase Program Number Of Shares Purchased
StockRepurchaseProgramNumberOfSharesPurchased
2054732 shares
CY2013Q2 forr Stock Repurchase Program Authorized Incremental Price Per Share
StockRepurchaseProgramAuthorizedIncrementalPricePerShare
0.25
CY2013Q2 forr Stock Repurchase Program Purchase Price Per Share
StockRepurchaseProgramPurchasePricePerShare
36.00
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
539000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
319000
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
32.98
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
30078000
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
772000
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
181329000
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
588000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
297070000
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
389362000
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
117648000
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
150479000
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
315000
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
487832000
CY2012Q4 us-gaap Liabilities
Liabilities
190762000
CY2012Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
9433000
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
134876000
CY2012Q4 us-gaap Assets Current
AssetsCurrent
336565000
CY2012Q4 us-gaap Goodwill
Goodwill
78954000
CY2012Q4 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
8970000
CY2012Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
145512000
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9123000
CY2012Q4 us-gaap Assets
Assets
487832000
CY2012Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
8970000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
98810000
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
74623000
CY2012Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1200000
CY2012Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
27146000
CY2012Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7920000
CY2012Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
143846000
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
18846000
CY2012Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
9410000
CY2012Q4 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
176774000
CY2012Q4 us-gaap Treasury Stock Value
TreasuryStockValue
210843000
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
46300000
CY2012Q4 forr Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
2073000
CY2012Q4 forr Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
407000
CY2012Q4 forr Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Aggregate Losses Accumulated In Investments
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsAggregateLossesAccumulatedInInvestments
43000
CY2012Q4 forr Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Aggregate Losses Accumulated In Investments
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerAggregateLossesAccumulatedInInvestments
2030000
dei Entity Registrant Name
EntityRegistrantName
FORRESTER RESEARCH, INC.
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
37231000
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2013-06-30
dei Entity Central Index Key
EntityCentralIndexKey
0001023313
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
52000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
207000 shares
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 Segment
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.36
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22202000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
30.79
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
421000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
31.49
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.37
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y1M24D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
32.91
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
34.91
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
746000 shares
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Note 9 &#x2014; Recent Accounting Pronouncements</b></font></p> <p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><font style="FONT-FAMILY: Times New Roman" size="2">In July 2012, the Financial Accounting Standards Board (&#x201C;FASB&#x201D;) issued ASU No.&#xA0;2012-02, Intangibles &#x2013; Goodwill and Other (Topic 350): Testing Indefinite-Lived Intangible Assets for Impairment. This accounting standard allows an entity the option to first assess qualitative factors to determine whether it is necessary to perform a quantitative impairment test for indefinite-lived intangibles other than goodwill. Under that option, an entity would no longer be required to calculate the fair value of an indefinite-lived intangible asset unless the entity determines, based on that qualitative assessment, that it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying amount. This ASU was effective for annual and interim indefinite-lived intangible asset impairment tests performed for fiscal years beginning after September&#xA0;15, 2012. As the Company does not have any indefinite-lived intangible assets as of June 30,&#xA0;2013 other than goodwill, the adoption of this standard on January&#xA0;1, 2013 did not have an impact on the Company&#x2019;s consolidated financial results.</font></font></p> <p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><font style="FONT-FAMILY: Times New Roman" size="2">In February 2013, the FASB issued ASU No. 2013-02, Comprehensive Income (Topic 220): Reporting Amounts Reclassified Out of Accumulated Other Comprehensive Income. This accounting standard requires companies to provide information about the amounts reclassified out of accumulated other comprehensive income by component. In addition, companies are required to present, either on the face of the statement where net income is presented or in the notes, significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income. This ASU is effective for reporting periods beginning after December 15, 2012. Other than requiring additional disclosures, adoption of this ASU did not have a significant impact on the Company&#x2019;s consolidated financial results.</font></font></p> </div>
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
24.70
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
430000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
34.58
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21781000 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y3M29D
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
408000 shares
us-gaap Restructuring And Related Cost Number Of Positions Eliminated Period Percent
RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent
0.025 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
52000 shares
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.30
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
67000 shares
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-5376000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-12955000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-34564000
us-gaap Net Income Loss
NetIncomeLoss
7963000
us-gaap Stock Repurchase Program Authorized Amount
StockRepurchaseProgramAuthorizedAmount
385000000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1755000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
15000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
92083000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1267000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-440000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
10513000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-2323000
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
302900000
us-gaap Share Based Compensation
ShareBasedCompensation
2728000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-43727000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
53846000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
34000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4619000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6208000
us-gaap Gain Loss On Investments
GainLossOnInvestments
-102000
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-560000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
12946000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-248000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
39636000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
6414000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
631000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-416000
us-gaap Operating Income Loss
OperatingIncomeLoss
12417000
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
149663000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
12946000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1339000
us-gaap Costs And Expenses
CostsAndExpenses
137246000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17907000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-88246000
us-gaap Cost Of Services
CostOfServices
57813000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
638000
us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
1265000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1113000
us-gaap Restructuring Charges
RestructuringCharges
1905000
us-gaap Depreciation
Depreciation
4662000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2728000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
49143000
us-gaap Dividends
Dividends
6400000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
82948000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4983000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-1200000
forr Other Income And Gains Losses On Investments
OtherIncomeAndGainsLossesOnInvestments
529000
forr Cash Bonus Plan Maturity Date
CashBonusPlanMaturityDate
2015-06-30
forr Advisory Services And Other
AdvisoryServicesAndOther
48773000
forr Direct Margin
DirectMargin
98383000
forr Number Of Jobs Eliminated Related To Severance And Related Costs
NumberOfJobsEliminatedRelatedToSeveranceAndRelatedCosts
31 Job
forr Payment Of Deferred Acquisition Consideration
PaymentOfDeferredAcquisitionConsideration
900000
forr Money Market Funds Original Maturities Period At Time Of Purchase
MoneyMarketFundsOriginalMaturitiesPeriodAtTimeOfPurchase
P90D
forr Research Services
ResearchServices
100890000
forr Cash Bonus Paid During Period Under Bonus Plan
CashBonusPaidDuringPeriodUnderBonusPlan
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.47
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.28
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23098000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
438000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.48
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
39399000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22660000 shares
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.28
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
483000 shares
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-239000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-234000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
10937000
us-gaap Gain Loss On Investments
GainLossOnInvestments
143000
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-2647000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
16771000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-124000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
65713000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
6356000
us-gaap Operating Income Loss
OperatingIncomeLoss
16089000
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
149353000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
16771000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-332000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-33661000
us-gaap Net Income Loss
NetIncomeLoss
10950000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-13000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
10000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
17052000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3245000
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-946000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
333000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
6634000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-130000
us-gaap Costs And Expenses
CostsAndExpenses
133264000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18256000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-17181000
us-gaap Cost Of Services
CostOfServices
56766000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4291000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-12944000
us-gaap Share Based Compensation
ShareBasedCompensation
2512000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
6616000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
51400000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-244000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
166000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15043000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
14000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
332000
us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
1460000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1200000
us-gaap Restructuring Charges
RestructuringCharges
1394000
us-gaap Depreciation
Depreciation
4248000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2512000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
52845000
us-gaap Dividends
Dividends
6400000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
79077000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5821000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-559000
forr Other Income And Gains Losses On Investments
OtherIncomeAndGainsLossesOnInvestments
682000
forr Advisory Services And Other
AdvisoryServicesAndOther
48521000
forr Direct Margin
DirectMargin
97760000
forr Payment Of Deferred Acquisition Consideration
PaymentOfDeferredAcquisitionConsideration
739000
forr Research Services
ResearchServices
100832000
CY2013Q1 us-gaap Stock Repurchase Program Authorized Amount
StockRepurchaseProgramAuthorizedAmount
50000000
CY2013Q2 forr Stock Repurchase Program Tender Offer Expenses
StockRepurchaseProgramTenderOfferExpenses
1100000
CY2013Q2 us-gaap Treasury Stock Shares Retired
TreasuryStockSharesRetired
11700000 shares
CY2013Q2 us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
302500000
CY2012Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.34
CY2012Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.14
CY2012Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23023000 shares
CY2012Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
440000 shares
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.34
CY2012Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22583000 shares
CY2012Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
559000 shares
CY2012Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6772000
CY2012Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
84000
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11675000
CY2012Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
130000
CY2012Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
16000
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
11461000
CY2012Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
79093000
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
11675000
CY2012Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1013000
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
7769000
CY2012Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-997000
CY2012Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
2000
CY2012Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
17000
CY2012Q2 us-gaap Costs And Expenses
CostsAndExpenses
67632000
CY2012Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8645000
CY2012Q2 us-gaap Cost Of Services
CostOfServices
29828000
CY2012Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
26267000
CY2012Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
26000
CY2012Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
1000
CY2012Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
586000
CY2012Q2 us-gaap Restructuring Charges
RestructuringCharges
51000
CY2012Q2 us-gaap Depreciation
Depreciation
2255000
CY2012Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1189000
CY2012Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
39068000
CY2012Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3906000
CY2012Q2 forr Other Income And Gains Losses On Investments
OtherIncomeAndGainsLossesOnInvestments
214000
CY2012Q2 forr Advisory Services And Other
AdvisoryServicesAndOther
28021000
CY2012Q2 forr Direct Margin
DirectMargin
51166000
CY2012Q2 forr Research Services
ResearchServices
51072000
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
CY2013Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21747000 shares
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21256000 shares
CY2013Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
295000 shares
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5268000
CY2013Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
-51000
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9203000
CY2013Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
255000
CY2013Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-370000
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
8999000
CY2013Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
78164000
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
9203000
CY2013Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
16000
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
5622000
CY2013Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-354000
CY2013Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
15000
CY2013Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-394000
CY2013Q2 us-gaap Costs And Expenses
CostsAndExpenses
69165000
CY2013Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8420000
CY2013Q2 us-gaap Cost Of Services
CostOfServices
30786000
CY2013Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
26789000
CY2013Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-238000
CY2013Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-24000
CY2013Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
554000
CY2013Q2 us-gaap Restructuring Charges
RestructuringCharges
314000
CY2013Q2 us-gaap Depreciation
Depreciation
2302000
CY2013Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
868000
CY2013Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
40430000
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3581000
CY2013Q2 forr Other Income And Gains Losses On Investments
OtherIncomeAndGainsLossesOnInvestments
204000
CY2013Q2 forr Advisory Services And Other
AdvisoryServicesAndOther
27652000
CY2013Q2 forr Direct Margin
DirectMargin
50297000
CY2013Q2 forr Research Services
ResearchServices
50512000

Files In Submission

Name View Source Status
0001193125-13-323276-index-headers.html Edgar Link pending
0001193125-13-323276-index.html Edgar Link pending
0001193125-13-323276.txt Edgar Link pending
0001193125-13-323276-xbrl.zip Edgar Link pending
d548537d10q.htm Edgar Link pending
d548537dex101.htm Edgar Link pending
d548537dex311.htm Edgar Link pending
d548537dex312.htm Edgar Link pending
d548537dex321.htm Edgar Link pending
d548537dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
forr-20130630.xml Edgar Link completed
forr-20130630.xsd Edgar Link pending
forr-20130630_cal.xml Edgar Link unprocessable
forr-20130630_def.xml Edgar Link unprocessable
forr-20130630_lab.xml Edgar Link unprocessable
forr-20130630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R1.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R10.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R11.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R12.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R13.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R14.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R15.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R16.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R17.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R18.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R19.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R2.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R20.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R21.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R22.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R23.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R24.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R25.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R26.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R27.xml Edgar Link unprocessable
R28.htm Edgar Link pending
R28.xml Edgar Link unprocessable
R29.htm Edgar Link pending
R29.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R3.xml Edgar Link unprocessable
R30.htm Edgar Link pending
R30.xml Edgar Link unprocessable
R31.htm Edgar Link pending
R31.xml Edgar Link unprocessable
R32.htm Edgar Link pending
R32.xml Edgar Link unprocessable
R33.htm Edgar Link pending
R33.xml Edgar Link unprocessable
R34.htm Edgar Link pending
R34.xml Edgar Link unprocessable
R35.htm Edgar Link pending
R35.xml Edgar Link unprocessable
R36.htm Edgar Link pending
R36.xml Edgar Link unprocessable
R37.htm Edgar Link pending
R37.xml Edgar Link unprocessable
R38.htm Edgar Link pending
R38.xml Edgar Link unprocessable
R39.htm Edgar Link pending
R39.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R4.xml Edgar Link unprocessable
R40.htm Edgar Link pending
R40.xml Edgar Link unprocessable
R41.htm Edgar Link pending
R41.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R5.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R6.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R7.xml Edgar Link unprocessable
R8.htm Edgar Link pending
R8.xml Edgar Link unprocessable
R9.htm Edgar Link pending
R9.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending